Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biogen financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$183.5
2024-10-29
Market Capitalization
$26.7 B
2024-10-29
Revenue
$9.8 B
FY, 2023
CreditSafe Score
?
Score changed on Dec 13, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 11.0B | 10.2B | 9.8B |
| Revenue growth, % | -18.3% | ||
| Cost of goods sold | 2.1B | 2.3B | 2.5B |
| Gross profit | 8.9B | 7.9B | 7.3B |
| Gross profit margin, % | 80.8% | ||
| General and administrative expense | 2.7B | 2.4B | 2.5B |
| Operating expense total | 6.0B | 4.3B | 6.0B |
| Depreciation and amortization | 881.3M | 365.9M | 240.6M |
| EBIT | 2.8B | ||
| EBIT margin, % | 25.9% | ||
| Pre tax profit | 1.7B | 3.6B | 1.3B |
| Income tax expense | 52.5M | 632.8M | 135.3M |
| Net Income | 1.7B | 3.0B | 1.2B |
| EPS | 10.4 | 20.0 | 7.0 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |